|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $16 and $32 | ||||||||||||||||||||
| Finished goods | ||||||||||||||||||||
| Raw materials | ||||||||||||||||||||
| Packaging | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total goodwill | ||||||||||||||||||||
| Long-term assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Commodities payable | ||||||||||||||||||||
| Accrued salary, wages and benefits | ||||||||||||||||||||
| Accrued legal | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Operating lease liabilities, current portion | ||||||||||||||||||||
| Due under factoring agreement | ||||||||||||||||||||
| Line of Credit With Bank | ||||||||||||||||||||
| Factoring Agreement | ||||||||||||||||||||
| Total due under factoring agreement | ||||||||||||||||||||
| Due under insurance premium finance agreements | ||||||||||||||||||||
| Finance lease liabilities, current portion | ||||||||||||||||||||
| Current portion of long-term debt | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease liabilities, less current portion | ||||||||||||||||||||
| Finance lease liabilities, less current portion | ||||||||||||||||||||
| Long-term debt, net of unamortized discount | ||||||||||||||||||||
| Derivative warrant liability | ||||||||||||||||||||
| Long-term liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders' deficit: | ||||||||||||||||||||
| Preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $150, 150 shares, issued and outstanding | ||||||||||||||||||||
| Series G Preferred Stock | ||||||||||||||||||||
| Total preferred stock, 20,000,000 shares authorized: Series G, convertible, 3,000 shares authorized, stated value $150, 150 shares, issued and outstanding | ||||||||||||||||||||
| Common stock, no par value, 15,000,000 shares authorized, 10,004,002 shares and 9,513,341 shares, issued and outstanding | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total shareholders' deficit | ||||||||||||||||||||
| Total liabilities and shareholders' deficit | ||||||||||||||||||||
Loading...